| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'24 | $1.70 | $0.71 | -58.0% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'24 | - | $724M | - |
Market Data
ARGX is currently trading at $811.79, giving ARGX a market cap of 43.50B and a P/E ratio of 33.7. Today's range spans $817.20–$851.92, with shares opening at $834.11 and moving down $10.34 (1.3%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 48/100.
Over the past year ARGX has traded between $456.60 and $810.00 - the current price is +77.8% off the 52-week low and +0.2% from the high.
ARGX is showing a SELL signal (32/100) with neutral sentiment (48/100). Price: $811.79 (near 52-week highs within $456.60–$810.00). (P/E: 33.7) At 43.50B in Healthcare market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.
Analyst coverage for ARGX becomes a double-edged factor in a SELL phase: at 43.50B in Healthcare market cap, active coverage is high enough that downgrade risk is real and impactful. The 32/100 technical reading and neutral sentiment (48/100) at $811.79 (near 52-week highs) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $456.60–$810.00 range establishes where that repricing lands.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines